Incontinence-Associated Dermatitis: Prevalence, Economic Impact, and the Benefits of Prevention. Incontinence-associated dermatitis or IAD is an inflammation of the skin that occurs when the skin comes into contact with urine and/or fecal matter, it can be both painful and embarrassing for patients and is a well-recognized risk factor for the development of pressure ulcers, whichRead More Incontinence-Associated Dermatitis: Prevalence, Economic Impact and the Benefits of Prevention
(soft music) – Mind body practices may be a useful edition to the traditional therapies prescribed by your Rheumatologist. (soft music) Yoga is a mind body therapy that works on breathing, meditation, and movement to improve health and wellbeing. While Yoga has not been studied in randomized trials in patients with psoriasis and psoriatic arthritis,Read More Using Mind and Body Practices to Improve Day-to-Day Living with Psoriatic Arthritis
Sinus issues are very common. The best estimates are that about 10 percent of the U.S. population suffers from sinus disease at some point during their lifetime and an important subset of these patients have chronic sinus disease and even a smaller subset have nasal polyps. And these are the most difficult conditions, and thinkRead More Treating Sinusitis
CANCER patients losing their hair could be a thing of the past – thanks to a new breakthrough The findings will offer hope to millions who suffer, arguably, one of the most distressing side effects of treatment Scientists in Manchester have discovered how to protect the hair follicle during chemo They hope it will helpRead More New cancer treatment stops patients losing their hair during chemo, docs say – Live News 24
– A lot of my patients ask me what to eat while on chemotherapy, and I don’t know that there is a specific diet to be followed. Now, a couple of side effects that can occur with some chemotherapy, and this is a very broad question, some of the side effects of chemotherapy can causeRead More How Should I Eat Before Starting Chemotherapy?
The 21-gene expression recurrence score provides prognostic information in hormone-receptor-positive breast cancer. Research has shown that patients with a recurrence score of more than 25 benefit from the combination of chemotherapy and endocrine therapy, and patients with recurrence score of less than 11 benefit from endocrine therapy alone. However, the benefit of chemoendocrine therapy forRead More Chemotherapy and Recurrence in Breast Cancer
So there are 4 stages of colon cancer and stage 4 is when the tumor has spread to other organs and surgery is typically not an option and these patients benefit from chemotherapy stage three patients are those individuals where the cancer from the colon has been removed but there’s evidence that cancer has migratedRead More Do All Colon Cancer Patients Need Chemotherapy?
HAT COMES OF THAT MEETING. NOW TO HEALTH LIVING – IF YOU’VE HEARD THE WORDS, YOU KNOW. WHEN A DOCTOR SAYS “YOU HAVE CANCER,” IT’S EASY TO GO DOWN THE RABBIT HOLE OF WORRY. ONE REASON U-C HEALTH IS HELPING SOME PATIENTS CHANNEL THEIR INNER CHILD. Rachel Dunaway/Cervical Cancer SurvivorBridie Orr/UC Health Clinical Operations ManagerRead More Coloring provides a positive path through chemotherapy
Oral chemotherapy is a very important part of the treatment of cancer. There are new drugs now available that can be very toxic and have a lot of issues to patients if they don’t have very good education and monitoring. Our project was to standardize teaching and monitoring of patients on oral chemotherapy. We noticedRead More Decreasing Emergency Visits by Standardizing Education of Patients on Oral Chemotherapy
Patients with cancer have an increased risk of venous thromboembolism. But parenteral thromboprophylaxis is not routinely recommended in practice guidelines because the absolute risk reduction is modest and parenteral thromboprophylaxis is associated with an increased risk of major bleeding as well as the inconvenience of daily injections. Could a direct oral anticoagulant such as apixaban,Read More Reducing the Risk of Thromboembolism in Cancer